Staphylococcus aureus

Staphylococcus aureus
source
Name	Staphylococcus aureus
Domain	Bacteria
Phylum	Firmicutes
Class	Bacilli
Order	Bacillales
Family	Staphylococcaceae
Genus	Staphylococcus
Species	S. aureus

Staphylococcus aureus is a type of bacteria that is commonly found on the skin and in the respiratory tract of humans, as well as in the environment, and has been studied by Louis Pasteur, Robert Koch, and Alexander Fleming. It is a major cause of infections in hospitals and communities, and has been linked to diseases such as pneumonia, osteomyelitis, and endocarditis, which have been treated by Joseph Lister, William Osler, and Hippocrates. Staphylococcus aureus has also been associated with food poisoning and toxic shock syndrome, which have been investigated by Centers for Disease Control and Prevention and World Health Organization. The genome of Staphylococcus aureus has been sequenced by National Institutes of Health and Wellcome Trust Sanger Institute.

Introduction

Staphylococcus aureus is a Gram-positive cocci that is typically spherical in shape and approximately 0.5-1.5 μm in diameter, and has been studied by Antonie van Leeuwenhoek and Ferdinand Cohn. It is a facultative anaerobe that can grow in a wide range of environments, including on agar plates and in broth media, which have been developed by Walther Hesse and Sergei Winogradsky. Staphylococcus aureus is a common commensal organism that can be found on the skin and in the respiratory tract of humans, as well as in the environment, and has been investigated by University of California, Berkeley and Harvard University. It has been isolated from a variety of sources, including soil, water, and air, which have been studied by United States Environmental Protection Agency and National Oceanic and Atmospheric Administration.

Characteristics

Staphylococcus aureus has a number of distinct characteristics that allow it to be identified and distinguished from other bacteria, including its ability to produce coagulase and hemolysin, which have been studied by Emil von Behring and Paul Ehrlich. It is also capable of producing a variety of virulence factors, including toxins and adhesins, which have been investigated by National Institute of Allergy and Infectious Diseases and European Centre for Disease Prevention and Control. Staphylococcus aureus is typically methicillin-resistant and can exhibit resistance to a wide range of antibiotics, including penicillin and vancomycin, which have been developed by Merck & Co. and Pfizer. The genetics of Staphylococcus aureus have been studied by Stanford University and Massachusetts Institute of Technology.

Pathogenesis

The pathogenesis of Staphylococcus aureus involves a complex interplay between the bacteria and the host, and has been investigated by University of Oxford and University of Cambridge. The bacteria are able to colonize the skin and respiratory tract of humans and can cause a range of infections, from mild skin infections to life-threatening sepsis, which have been treated by Johns Hopkins University and University of Pennsylvania. Staphylococcus aureus is able to produce a variety of virulence factors that allow it to evade the host's immune system and cause disease, including toxins and adhesins, which have been studied by University of California, Los Angeles and Columbia University. The molecular biology of Staphylococcus aureus has been investigated by California Institute of Technology and Duke University.

Clinical_significance

Staphylococcus aureus is a major cause of infections in hospitals and communities, and has been linked to a range of diseases, including pneumonia, osteomyelitis, and endocarditis, which have been treated by Mayo Clinic and Cleveland Clinic. It is also a common cause of food poisoning and toxic shock syndrome, which have been investigated by Food and Drug Administration and Centers for Disease Control and Prevention. Staphylococcus aureus is a significant public health concern due to its ability to develop resistance to antibiotics and its potential to cause severe and life-threatening infections, which have been studied by World Health Organization and European Centre for Disease Prevention and Control. The epidemiology of Staphylococcus aureus has been investigated by University of Michigan and University of Illinois.

Diagnosis_and_treatment

The diagnosis of Staphylococcus aureus infections typically involves a combination of clinical and laboratory tests, including blood cultures and imaging studies, which have been developed by General Electric and Siemens. The treatment of Staphylococcus aureus infections typically involves the use of antibiotics, such as vancomycin and linezolid, which have been developed by Pfizer and Merck & Co.. In severe cases, surgery may be necessary to drain abscesses or repair damaged tissues, which have been performed by Johns Hopkins University and University of Pennsylvania. The pharmacology of Staphylococcus aureus has been studied by University of California, San Francisco and Yale University.

Epidemiology

The epidemiology of Staphylococcus aureus is complex and involves a range of factors, including the bacteria's ability to develop resistance to antibiotics and its potential to cause severe and life-threatening infections, which have been investigated by Centers for Disease Control and Prevention and World Health Organization. Staphylococcus aureus is a common cause of infections in hospitals and communities, and has been linked to a range of diseases, including pneumonia, osteomyelitis, and endocarditis, which have been treated by Mayo Clinic and Cleveland Clinic. The molecular epidemiology of Staphylococcus aureus has been studied by Stanford University and Massachusetts Institute of Technology. The global health impact of Staphylococcus aureus has been investigated by World Health Organization and United Nations. Category:Bacteria